Exane Derivatives’s The Gap Inc GAP Stock Holding History
Bought
Maintained
Sold
Other funds holding GAP
Exane Derivatives's GAP Position: Q2 2022 in Review
Exane Derivatives sold out of The Gap Inc (GAP) in Q2 2022, closing a stake of 243 shares — an estimated $3.42K sold.
Exane Derivatives first reported a position in GAP in Q4 2014 and held it in 25 quarters. The position peaked at $4.57M in Q2 2019. 357 funds tracked by Wall St. Rank hold GAP as of Q2 2022.
- Exane Derivatives reported no remaining The Gap Inc position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 243 The Gap Inc shares in Q2 2022, an estimated $3.42K.
- Exane Derivatives first reported a position in The Gap Inc in Q4 2014 and held it in 25 quarters.
- Exane Derivatives's The Gap Inc position peaked at $4.57M in Q2 2019.
- 357 funds tracked by Wall St. Rank held The Gap Inc as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.